Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
Authors
Keywords
-
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-09-01
DOI
10.1007/s00432-022-04162-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel insights into the interaction between N6-methyladenosine modification and circular RNA
- (2022) Tao Xu et al. Molecular Therapy-Nucleic Acids
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genetic variation and recurrent haplotypes on chromosome 6q23-25 risk locus in familial lung cancer
- (2021) Anthony M. Musolf et al. CANCER RESEARCH
- FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2
- (2021) Fei Xu et al. Molecular Cancer
- N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients
- (2021) Wei Song et al. Genes
- Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy
- (2021) Zezhen Liu et al. Frontiers in Immunology
- Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma
- (2021) Peilin Cong et al. Frontiers in Cell and Developmental Biology
- lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus
- (2021) Hai-Ting Liu et al. CELL DEATH AND DIFFERENTIATION
- METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway
- (2021) Chunli Xia et al. TOXICOLOGY
- Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer
- (2020) Wenhui Li et al. Journal of Translational Medicine
- The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
- (2020) Tao Liu et al. NUCLEIC ACIDS RESEARCH
- Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types
- (2020) Eric D. Routh et al. Frontiers in Immunology
- Targeting tumor microenvironment in ovarian cancer: Premise and promise
- (2020) Yuting Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers
- (2020) Shuang Deng et al. BRIEFINGS IN BIOINFORMATICS
- RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF‐ κ B pathway
- (2020) Yi Jiang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Inhibiting the coregulator CoREST impairs Foxp3+ Treg function and promotes antitumor immunity
- (2020) Yan Xiong et al. JOURNAL OF CLINICAL INVESTIGATION
- m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
- (2020) Bo Zhang et al. Molecular Cancer
- Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
- (2020) Yi Chen et al. Molecular Cancer
- The RNA modification N6-methyladenosine as a novel regulator of the immune system
- (2020) Ziv Shulman et al. NATURE IMMUNOLOGY
- YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation
- (2020) Chuanzhao Zhang et al. ONCOGENE
- Functional Link between miR-200a and ELK3 Regulates the Metastatic Nature of Breast Cancer
- (2020) Hyung-Keun Kim et al. Cancers
- Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer
- (2020) Xi Yang et al. BMC CANCER
- Clinical Challenges of Immune Checkpoint Inhibitors
- (2020) Maria de Miguel et al. CANCER CELL
- Multi-Omics data analyses construct tumor microenvironment and identify the immune-related prognosis signatures in human lung adenocarcinoma
- (2020) Yuwei Zhang et al. Molecular Therapy-Nucleic Acids
- A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer
- (2020) Lili Fan et al. Aging-US
- METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway
- (2020) Xuehan Bi et al. CANCER GENE THERAPY
- YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells
- (2020) Jie Li et al. Journal of Ovarian Research
- Hedgehog Signaling and Truncated GLI1 in Cancer
- (2020) Daniel Doheny et al. Cells
- m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells
- (2020) Liang Hao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- High ELK3 expression is associated with the VEGF-C/VEGFR-3 axis and gastric tumorigenesis and enhances infiltration of M2 macrophages
- (2020) Wang Dazhi et al. Future Medicinal Chemistry
- LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression
- (2020) Liwei Meng et al. Cell Death & Disease
- Clinicopathological and immunological characterization of RNA m 6 A methylation regulators in ovarian cancer
- (2020) Qingying Wang et al. Molecular Genetics & Genomic Medicine
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
- (2019) Maosheng Cheng et al. ONCOGENE
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
- (2019) Jie Han et al. Molecular Cancer
- METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
- (2019) Ben Yue et al. Molecular Cancer
- Precision medicine for human cancers with Notch signaling dysregulation (Review)
- (2019) Masuko Katoh et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2
- (2018) Peng Deng et al. CARCINOGENESIS
- Notch Signaling in the Tumor Microenvironment
- (2018) Olivier Meurette et al. CANCER CELL
- METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition
- (2018) Wenfeng Hua et al. GYNECOLOGIC ONCOLOGY
- m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
- (2018) Jun Liu et al. NATURE CELL BIOLOGY
- Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy
- (2018) Kaiwei Liang et al. CELL
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- Calcium signalling links MYC to NUAK1
- (2017) T Monteverde et al. ONCOGENE
- Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4
- (2017) Junjie Xiao et al. Theranostics
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer
- (2016) Neil T. Phippen et al. Frontiers in Oncology
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer
- (2015) HAI-YAN ZHANG et al. ONCOLOGY REPORTS
- Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
- (2014) Markus Riester et al. JNCI-Journal of the National Cancer Institute
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Genome-Wide Association Study Reveals Novel Genetic Determinants of DNA Repair Capacity in Lung Cancer
- (2012) L.-E. Wang et al. CANCER RESEARCH
- Variant Ciz1 is a circulating biomarker for early-stage lung cancer
- (2012) G. Higgins et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
- (2010) Matthew D. Wilkerson et al. BIOINFORMATICS
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started